Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species

Infection Control and Hospital Epidemiology

Volumn 38, Issue 9, 2017, Pages 1107-1109

  Piedrahita, Christina T ^a   Cadnum, Jennifer L ^a   Jencson, Annette L ^a   Shaikh, Aaron A ^b   Ghannoum, Mahmoud A ^c,d   Donskey, Curtis J ^a,b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA; EAR; HEALTH CARE FACILITY; NONHUMAN; SPECIES; CANDIDIASIS; COMPARATIVE STUDY; CROSS INFECTION; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MEDICAL DEVICE CONTAMINATION; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; STATISTICAL MODEL;

CANDIDA; CANDIDIASIS; CROSS INFECTION; EQUIPMENT CONTAMINATION; HOSPITALS; HUMANS; LOGISTIC MODELS; MICROBIAL SENSITIVITY TESTS;

EID: 85023174802     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.127     Document Type: Article

References (10)

1. Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013-August 2016. Am J Transplant 2017; 17: 296-299.
2. Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist. Infect Control 2016; 5: 35.
3. Calvo B, Melo AS, Perozo-Mena A, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect 2016; 73: 369-374.
4. Larkin E, Hager C, Chandra J, et al. The emerging Candida auris: characterization of growth phenotype, virulence factors, antifungal activity, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 2017; Feb 21. pii: AAC. 02396-16.
5. Candida auris. Centers for Disease Control and Prevention website. https://www. cdc. gov/fungal/diseases/candidiasis/candidaauris. html. Updated May 12, 2017. Accessed June 2, 2017.
6. Kramer A, Schweke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130.
7. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22(Suppl 2): S89-S94.
8. Mizusawa M, Miller H, Green R, et al. Can multidrug-resistant Candida auris be reliably identified in clinical microbiology laboratories? J Clin Microbiol 2017; 55: 638-640.
9. Nerandzic MM, Cadnum JL, Pultz MJ, Donskey CJ. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis 2010; 10: 197.
10. Kotay S, Chai W, Guilford W, et al. Spread from the sink to the patient: in situ study using green fluorescent protein (GFP)-expressing Escherichia coli to model bacterial dispersion from hand washing sink trap reservoirs. Appl Environ Microbiol 2017 Feb 24. pii: AEM. 03327-16.